e-Article
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
Document Type
Article
Author
Source
In Biology of Blood and Marrow Transplantation August 2015 21(8):1445-1451
Subject
Language
ISSN
1083-8791